In the newly appointed role, Vaughn will lead and oversee all of the company’s sales activities.
Previously, Vaughn has worked as senior vice president of sales at Shire from 1992 to 2005.
Prior to Shire, Vaughn has served in various positions in sales and sales management at Fujisawa and SmithKline Beecham (Glaxo).
The company added that Vaughn brings to his new position over 30 years of experience in the pharmaceutical industry, including consulting with small to medium size pharmaceutical companies.
Samsung Biologics honoured at 2026 CDMO Leadership Awards
Frost & Sullivan names Abzena a market-leading ADC CDMO
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
SportsMed Physical Therapy named Physical Therapy Company of the Year
Ensorcell adds new senior leadership team members
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme